Clinical trials
3 active trials worldwide
Recruiting, about to start, or running now.
- Rickettsia Clearance Study NCT05972772
- Scrub Typhus Antibiotic Resistance Trial NCT03083197
- Scrub Typhus Infection Induced Cardiovascular Disease NCT03274869
Global Scrub Typhus Public Health Report: Disease Burden, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook
| Country | Deaths under age 5per 1,000 live births | Basic drinking waterof people | Universal health coverage indexindex (0–100) | Health spending from abroadof health spending |
|---|---|---|---|---|
| 30.5 2024 | 99% 2024 | 54 2023 | 3.5% 2023 | |
| 26.6 2024 | 96% 2024 | 69 2023 | 2.4% 2023 | |
| 17.7 2024 | 89% 2024 | 67 2023 | 0.6% 2023 | |
| 36.9 2024 | 86% 2024 | 52 2023 | 6.1% 2023 | |
| 25.1 2024 | 94% 2024 | 58 2023 | 6.9% 2023 | |
| 26.5 2024 | 96% 2024 | 69 2023 | 0.1% 2023 |
Sources: World Bank, World Health Organization. A dash means no recent published figure.
Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.
| Topic | Scrub Typhus |
|---|---|
| Place | Global |
| Deaths under age 5 (latest) | 37.4 per 1,000 live births (2024)Source: World Bank Open Data, Deaths under age 5 (per 1,000 live births). Retrieved 22 Nov 2026. |
| Report sections | 16 (table of contents) |
| Active clinical trials | 3 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Scrub typhus is a bacterial infection spread by mite bites in rural Asia, a common and under-recognised cause of fever. This report covers uncomplicated scrub typhus and severe scrub typhus.
The report sets out the prevalence, incidence and, where relevant, deaths from scrub typhus worldwide, and the overall burden, using Reported Cases, Case Fatality Rate, Hospital Admissions, Outbreak Frequency and Laboratory Confirmation Rate.
The burden is broken down by age (children under 5, children 5–14 years, adults 15–64 years and adults 65 years and over), gender and income, with a focus on children under five, older adults, people with weak immunity, health workers, displaced people and people without safe water.
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Main risk factors include unsafe water and food, contact with animals, crowding and displacement, weak infection control, climate and seasonal change and low vaccination. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
The report reviews how aware people are of scrub typhus and how far screening reaches them, through clinical surveillance, laboratory confirmation, rapid diagnostic tests and outbreak investigation, by group and by area.
It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.
Treatment and prevention covered include doxycycline treatment, rapid diagnostic tests, clinician awareness and protective clothing, with how many people receive treatment and how many stay on it.
Long-term effects covered include deaths, long-term complications, outbreak spread and disruption of health services, along with other conditions that often occur alongside scrub typhus.
The report looks at hospitals and isolation units, public health laboratories, rapid response teams and surveillance systems, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).[2] People pay 17.3% of all health spending out of their own pockets (2023).[3] ClinicalTrials.gov lists 3 studies on Scrub Typhus that are recruiting, active or about to start worldwide.[4]
[1] World Health Organization, universal health coverage. Checked 14 Nov 2026.
[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 22 Nov 2026.
[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 21 Nov 2026.
[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
It describes the costs of scrub typhus to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.
Worldwide guidance and funding for scrub typhus include WHO International Health Regulations (2005), WHO Health Emergencies Programme, Global Outbreak Alert and Response Network (GOARN) and Africa CDC. The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
It looks ahead at the likely future burden of scrub typhus, the healthcare it will need and the areas most vulnerable.
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO Disease Outbreak News, WHO Global Health Observatory, National Disease Surveillance Systems and Africa CDC Epidemic Intelligence Reports. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
What doctors and scientists are doing in Scrub Typhus Public Health Report right now, from free public sources.
3 active trials worldwide
Recruiting, about to start, or running now.
37.4 per 1,000 live births
Deaths under age 5, World, 2024 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Medical Devices · Global
Medical Devices · Global
Pharmaceuticals · Global
OTC & Nutraceuticals · Global
Pharmaceuticals · Global
Medical Devices · Global